Breaking News

Paragon, NIAID in Preclinical Drug Development Pact

Multiple award IDIQ contract valued up to $159M

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Paragon Bioservices has received a multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract to provide product development services for a variety of National Institute of Allergy and Infectious Diseases (NIAID) medical product development activities. The IDIQ mechanism will allow Paragon to compete within a contractor pool for task order awards up to $159 million. Paragon is one of four awardees to receive the IDIQ valued up to $159 million, with a period of performance of up ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters